Local view for "http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/DB03229"
Predicate | Value (sorted: default) |
---|---|
rdfs:label |
"2-Oxo-4-Methylpentanoic Acid"
|
rdf:type | |
ns1:description |
"
experimental
# Martin PM, Gopal E, Ananth S, Zhuang L, Itagaki S, Prasad BM, Smith SB, Prasad PD, Ganapathy V: Identity of SMCT1 (SLC5A8) as a neuron-specific Na+-coupled transporter for active uptake of L-lactate and ketone bodies in the brain. J Neurochem. 2006 Jul;98(1):279-88. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/16805814
This compound belongs to the alpha keto-acids and derivatives. These are organic compounds containing an aldehyde substituted with a keto group on the adjacent carbon.
Alpha Keto-Acids and Derivatives
Organic Compounds
Organic Acids and Derivatives
Keto-Acids and Derivatives
Alpha Keto-Acids and Derivatives
Ketones
Polyamines
Enolates
Carboxylic Acids
Keto Acids and Derivatives
ketone
enolate
polyamine
carboxylic acid
carboxylic acid derivative
carbonyl group
logP
0.82
ALOGPS
logS
-1.3
ALOGPS
Water Solubility
6.76e+00 g/l
ALOGPS
logP
1.5
ChemAxon
IUPAC Name
4-methyl-2-oxopentanoic acid
ChemAxon
Traditional IUPAC Name
α-ketoisocaproic acid
ChemAxon
Molecular Weight
130.1418
ChemAxon
Monoisotopic Weight
130.062994186
ChemAxon
SMILES
CC(C)CC(=O)C(O)=O
ChemAxon
Molecular Formula
C6H10O3
ChemAxon
InChI
InChI=1S/C6H10O3/c1-4(2)3-5(7)6(8)9/h4H,3H2,1-2H3,(H,8,9)
ChemAxon
InChIKey
InChIKey=BKAJNAXTPSGJCU-UHFFFAOYSA-N
ChemAxon
Polar Surface Area (PSA)
54.37
ChemAxon
Refractivity
31.77
ChemAxon
Polarizability
13
ChemAxon
Rotatable Bond Count
3
ChemAxon
H Bond Acceptor Count
3
ChemAxon
H Bond Donor Count
1
ChemAxon
pKa (strongest acidic)
3.53
ChemAxon
pKa (strongest basic)
-9.7
ChemAxon
Physiological Charge
-1
ChemAxon
Number of Rings
0
ChemAxon
Bioavailability
1
ChemAxon
Rule of Five
true
ChemAxon
ChEBI
48430
PubChem Compound
70
PubChem Substance
46506016
PDB
COI
SMP00137
2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency
DB00121
Biotin
DB00139
Succinic acid
DB00142
L-Glutamic Acid
DB00147
Pyridoxal
DB00161
L-Valine
DB00167
L-Isoleucine
DB03229
2-Oxo-4-Methylpentanoic Acid
DB04074
Alpha-ketoisovalerate
P21953
P12694
P09622
P35914
P54687
P11182
P26440
P11310
P30084
Q96RQ3
Q9HCC0
P16219
P45954
Q9UKU7
Q6NVY1
P31937
P80404
Q99714
P42765
Q02252
P05165
P05166
Q96PE7
P22033
Q06278
P05091
Q13825
P54868
P24752
P55809
SMP00138
3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency
DB00121
Biotin
DB00139
Succinic acid
DB00142
L-Glutamic Acid
DB00147
Pyridoxal
DB00161
L-Valine
DB00167
L-Isoleucine
DB03229
2-Oxo-4-Methylpentanoic Acid
DB04074
Alpha-ketoisovalerate
P21953
P12694
P09622
P35914
P54687
P11182
P26440
P11310
P30084
Q96RQ3
Q9HCC0
P16219
P45954
Q9UKU7
Q6NVY1
P31937
P80404
Q99714
P42765
Q02252
P05165
P05166
Q96PE7
P22033
Q06278
P05091
Q13825
P54868
P24752
P55809
SMP00522
3-hydroxyisobutyric aciduria
DB00121
Biotin
DB00139
Succinic acid
DB00142
L-Glutamic Acid
DB00147
Pyridoxal
DB00161
L-Valine
DB00167
L-Isoleucine
DB03229
2-Oxo-4-Methylpentanoic Acid
DB04074
Alpha-ketoisovalerate
P21953
P12694
P09622
P35914
P54687
P11182
P26440
P11310
P30084
Q96RQ3
Q9HCC0
P16219
P45954
Q9UKU7
Q6NVY1
P31937
P80404
Q99714
P42765
Q02252
P05165
P05166
Q96PE7
P22033
Q06278
P05091
Q13825
P54868
P24752
P55809
SMP00141
3-Methylglutaconic Aciduria Type IV
DB00121
Biotin
DB00139
Succinic acid
DB00142
L-Glutamic Acid
DB00147
Pyridoxal
DB00161
L-Valine
DB00167
L-Isoleucine
DB03229
2-Oxo-4-Methylpentanoic Acid
DB04074
Alpha-ketoisovalerate
P21953
P12694
P09622
P35914
P54687
P11182
P26440
P11310
P30084
Q96RQ3
Q9HCC0
P16219
P45954
Q9UKU7
Q6NVY1
P31937
P80404
Q99714
P42765
Q02252
P05165
P05166
Q96PE7
P22033
Q06278
P05091
Q13825
P54868
P24752
P55809
SMP00139
3-Methylglutaconic Aciduria Type I
DB00121
Biotin
DB00139
Succinic acid
DB00142
L-Glutamic Acid
DB00147
Pyridoxal
DB00161
L-Valine
DB00167
L-Isoleucine
DB03229
2-Oxo-4-Methylpentanoic Acid
DB04074
Alpha-ketoisovalerate
P21953
P12694
P09622
P35914
P54687
P11182
P26440
P11310
P30084
Q96RQ3
Q9HCC0
P16219
P45954
Q9UKU7
Q6NVY1
P31937
P80404
Q99714
P42765
Q02252
P05165
P05166
Q96PE7
P22033
Q06278
P05091
Q13825
P54868
P24752
P55809
SMP00521
3-hydroxyisobutyric acid dehydrogenase deficiency
DB00121
Biotin
DB00139
Succinic acid
DB00142
L-Glutamic Acid
DB00147
Pyridoxal
DB00161
L-Valine
DB00167
L-Isoleucine
DB03229
2-Oxo-4-Methylpentanoic Acid
DB04074
Alpha-ketoisovalerate
P21953
P12694
P09622
P35914
P54687
P11182
P26440
P11310
P30084
Q96RQ3
Q9HCC0
P16219
P45954
Q9UKU7
Q6NVY1
P31937
P80404
Q99714
P42765
Q02252
P05165
P05166
Q96PE7
P22033
Q06278
P05091
Q13825
P54868
P24752
P55809
SMP00237
3-Methylcrotonyl Coa Carboxylase Deficiency Type I
DB00121
Biotin
DB00139
Succinic acid
DB00142
L-Glutamic Acid
DB00147
Pyridoxal
DB00161
L-Valine
DB00167
L-Isoleucine
DB03229
2-Oxo-4-Methylpentanoic Acid
DB04074
Alpha-ketoisovalerate
P21953
P12694
P09622
P35914
P54687
P11182
P26440
P11310
P30084
Q96RQ3
Q9HCC0
P16219
P45954
Q9UKU7
Q6NVY1
P31937
P80404
Q99714
P42765
Q02252
P05165
P05166
Q96PE7
P22033
Q06278
P05091
Q13825
P54868
P24752
P55809
SMP00140
3-Methylglutaconic Aciduria Type III
DB00121
Biotin
DB00139
Succinic acid
DB00142
L-Glutamic Acid
DB00147
Pyridoxal
DB00161
L-Valine
DB00167
L-Isoleucine
DB03229
2-Oxo-4-Methylpentanoic Acid
DB04074
Alpha-ketoisovalerate
P21953
P12694
P09622
P35914
P54687
P11182
P26440
P11310
P30084
Q96RQ3
Q9HCC0
P16219
P45954
Q9UKU7
Q6NVY1
P31937
P80404
Q99714
P42765
Q02252
P05165
P05166
Q96PE7
P22033
Q06278
P05091
Q13825
P54868
P24752
P55809
SMP00236
Propionic Acidemia
DB00121
Biotin
DB00139
Succinic acid
DB00142
L-Glutamic Acid
DB00147
Pyridoxal
DB00161
L-Valine
DB00167
L-Isoleucine
DB03229
2-Oxo-4-Methylpentanoic Acid
DB04074
Alpha-ketoisovalerate
P21953
P12694
P09622
P35914
P54687
P11182
P26440
P11310
P30084
Q96RQ3
Q9HCC0
P16219
P45954
Q9UKU7
Q6NVY1
P31937
P80404
Q99714
P42765
Q02252
P05165
P05166
Q96PE7
P22033
Q06278
P05091
Q13825
P54868
P24752
P55809
SMP00524
Isovaleric acidemia
DB00121
Biotin
DB00139
Succinic acid
DB00142
L-Glutamic Acid
DB00147
Pyridoxal
DB00161
L-Valine
DB00167
L-Isoleucine
DB03229
2-Oxo-4-Methylpentanoic Acid
DB04074
Alpha-ketoisovalerate
P21953
P12694
P09622
P35914
P54687
P11182
P26440
P11310
P30084
Q96RQ3
Q9HCC0
P16219
P45954
Q9UKU7
Q6NVY1
P31937
P80404
Q99714
P42765
Q02252
P05165
P05166
Q96PE7
P22033
Q06278
P05091
Q13825
P54868
P24752
P55809
SMP00200
Methylmalonic Aciduria
DB00121
Biotin
DB00139
Succinic acid
DB00142
L-Glutamic Acid
DB00147
Pyridoxal
DB00161
L-Valine
DB00167
L-Isoleucine
DB03229
2-Oxo-4-Methylpentanoic Acid
DB04074
Alpha-ketoisovalerate
P21953
P12694
P09622
P35914
P54687
P11182
P26440
P11310
P30084
Q96RQ3
Q9HCC0
P16219
P45954
Q9UKU7
Q6NVY1
P31937
P80404
Q99714
P42765
Q02252
P05165
P05166
Q96PE7
P22033
Q06278
P05091
Q13825
P54868
P24752
P55809
SMP00238
Isovaleric Aciduria
DB00121
Biotin
DB00139
Succinic acid
DB00142
L-Glutamic Acid
DB00147
Pyridoxal
DB00161
L-Valine
DB00167
L-Isoleucine
DB03229
2-Oxo-4-Methylpentanoic Acid
DB04074
Alpha-ketoisovalerate
P21953
P12694
P09622
P35914
P54687
P11182
P26440
P11310
P30084
Q96RQ3
Q9HCC0
P16219
P45954
Q9UKU7
Q6NVY1
P31937
P80404
Q99714
P42765
Q02252
P05165
P05166
Q96PE7
P22033
Q06278
P05091
Q13825
P54868
P24752
P55809
SMP00032
Valine, Leucine and Isoleucine Degradation
DB00121
Biotin
DB00139
Succinic acid
DB00142
L-Glutamic Acid
DB00147
Pyridoxal
DB00161
L-Valine
DB00167
L-Isoleucine
DB03229
2-Oxo-4-Methylpentanoic Acid
DB04074
Alpha-ketoisovalerate
P21953
P12694
P09622
P35914
P54687
P11182
P26440
P11310
P30084
Q96RQ3
Q9HCC0
P16219
P45954
Q9UKU7
Q6NVY1
P31937
P80404
Q99714
P42765
Q02252
P05165
P05166
Q96PE7
P22033
Q06278
P05091
Q13825
P54868
P24752
P55809
SMP00173
Beta-Ketothiolase Deficiency
DB00121
Biotin
DB00139
Succinic acid
DB00142
L-Glutamic Acid
DB00147
Pyridoxal
DB00161
L-Valine
DB00167
L-Isoleucine
DB03229
2-Oxo-4-Methylpentanoic Acid
DB04074
Alpha-ketoisovalerate
P21953
P12694
P09622
P35914
P54687
P11182
P26440
P11310
P30084
Q96RQ3
Q9HCC0
P16219
P45954
Q9UKU7
Q6NVY1
P31937
P80404
Q99714
P42765
Q02252
P05165
P05166
Q96PE7
P22033
Q06278
P05091
Q13825
P54868
P24752
P55809
SMP00523
Isobutyryl-coa dehydrogenase deficiency
DB00121
Biotin
DB00139
Succinic acid
DB00142
L-Glutamic Acid
DB00147
Pyridoxal
DB00161
L-Valine
DB00167
L-Isoleucine
DB03229
2-Oxo-4-Methylpentanoic Acid
DB04074
Alpha-ketoisovalerate
P21953
P12694
P09622
P35914
P54687
P11182
P26440
P11310
P30084
Q96RQ3
Q9HCC0
P16219
P45954
Q9UKU7
Q6NVY1
P31937
P80404
Q99714
P42765
Q02252
P05165
P05166
Q96PE7
P22033
Q06278
P05091
Q13825
P54868
P24752
P55809
SMP00384
Methylmalonate Semialdehyde Dehydrogenase Deficiency
DB00121
Biotin
DB00139
Succinic acid
DB00142
L-Glutamic Acid
DB00147
Pyridoxal
DB00161
L-Valine
DB00167
L-Isoleucine
DB03229
2-Oxo-4-Methylpentanoic Acid
DB04074
Alpha-ketoisovalerate
P21953
P12694
P09622
P35914
P54687
P11182
P26440
P11310
P30084
Q96RQ3
Q9HCC0
P16219
P45954
Q9UKU7
Q6NVY1
P31937
P80404
Q99714
P42765
Q02252
P05165
P05166
Q96PE7
P22033
Q06278
P05091
Q13825
P54868
P24752
P55809
SMP00199
Maple Syrup Urine Disease
DB00121
Biotin
DB00139
Succinic acid
DB00142
L-Glutamic Acid
DB00147
Pyridoxal
DB00161
L-Valine
DB00167
L-Isoleucine
DB03229
2-Oxo-4-Methylpentanoic Acid
DB04074
Alpha-ketoisovalerate
P21953
P12694
P09622
P35914
P54687
P11182
P26440
P11310
P30084
Q96RQ3
Q9HCC0
P16219
P45954
Q9UKU7
Q6NVY1
P31937
P80404
Q99714
P42765
Q02252
P05165
P05166
Q96PE7
P22033
Q06278
P05091
Q13825
P54868
P24752
P55809
BE0001833
Deacetoxycephalosporin C synthase
Streptomyces clavuligerus (strain ATCC 27064 / DSM 738 / JCM 4710 / NBRC 13307 / NCIMB 12785 / NRRL 3585 / VKM Ac-602)
# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284
# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423
unknown
Deacetoxycephalosporin C synthase
Involved in iron ion binding
Catalyzes the step from penicillin N to deacetoxy- cephalosporin C
cefE
None
4.94
34556.0
Streptomyces clavuligerus (strain ATCC 27064 / DSM 738 / JCM 4710 / NBRC 13307 / NCIMB 12785 / NRRL 3585 / VKM Ac-602)
GenBank Gene Database
M32324
GenBank Protein Database
153205
UniProtKB
P18548
UniProt Accession
CEFE_STRC2
DAOCS
EC 1.14.20.1
Expandase
>Deacetoxycephalosporin C synthetase
MDTTVPTFSLAELQQGLHQDEFRRCLRDKGLFYLTDCGLTDTELKSAKDLVIDFFEHGSE
AEKRAVTSPVPTMRRGFTGLESESTAQITNTGSYSDYSMCYSMGTADNLFPSGDFERIWT
QYFDRQYTASRAVAREVLRATGTEPDGGVEAFLDCEPLLRFRYFPQVPEHRSAEEQPLRM
APHYDLSMVTLIQQTPCANGFVSLQAEVGGAFTDLPYRPDAVLVFCGAIATLVTGGQVKA
PRHHVAAPRRDQIAGSSRTSSVFFLRPNADFTFSVPLARECGFDVSLDGETATFQDWIGG
NYVNIRRTSKA
>936 bp
ATGGACACGACGGTGCCCACCTTCAGCCTGGCCGAACTCCAGCAGGGCCTGCACCAGGAC
GAGTTCCGCAGGTGTCTGAGGGACAAGGGCCTCTTCTATCTGACGGACTGCGGTCTGACC
GACACCGAGCTGAAGTCGGCCAAGGACCTCGTCATCGACTTCTTCGAGCACGGCAGCGAG
GCGGAGAAGCGCGCCGTCACCTCGCCCGTCCCCACCATGCGCCGCGGCTTCACCGGGCTG
GAGTCGGAGAGCACCGCCCAGATCACCAATACCGGCAGCTACTCCGACTACTCGATGTGC
TACTCGATGGGCACCGCGGACAACCTCTTCCCGTCCGGTGACTTCGAGCGGATCTGGACC
CAGTACTTCGACCGCCAGTACACCGCCTCCCGCGCGGTCGCCCGGGAGGTCCTGCGGGCG
ACCGGGACCGAGCCCGACGGCGGGGTCGAGGCCTTCCTCGACTGCGAGCCGCTGCTGCGG
TTCCGCTACTTCCCGCAGGTCCCCGAGCACCGCAGCGCCGAGGAGCAGCCCCTGCGGATG
GCGCCGCACTACGACCTGTCGATGGTCACCCTCATCCAGCAGACACCCTGCGCCAACGGC
TTCGTCAGCCTCCAGGCCGAGGTCGGCGGCGCGTTCACGGACCTGCCCTACCGTCCGGAC
GCCGTCCTCGTCTTCTGCGGCGCCATCGCGACCCTGGTGACCGGCGGCCAGGTCAAGGCC
CCCCGGCACCATGTCGCGGCCCCCCGCAGGGACCAGATAGCGGGCAGCAGCCGCACCTCC
AGTGTGTTCTTCCTCCGTCCCAACGCGGACTTCACCTTCTCCGTCCCGCTGGCGCGCGAG
TGCGGCTTCGATGTCAGCCTGGACGGCGAGACCGCCACGTTCCAGGATTGGATCGGGGGC
AACTACGTGAACATCCGCCGCACATCCAAGGCATAG
PF03171
2OG-FeII_Oxy
function
cation binding
function
transition metal ion binding
function
iron ion binding
function
binding
function
catalytic activity
function
oxidoreductase activity
function
ion binding
process
biosynthesis
process
physiological process
process
metabolism
BE0001866
D-2-hydroxyisocaproate dehydrogenase
Lactobacillus paracasei
# Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17139284
# Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/17016423
unknown
D-2-hydroxyisocaproate dehydrogenase
Energy production and conversion
Catalyzes the NAD dependent reversible, stereospecific interconversion between 2-ketocarboxylic acids and D-2-hydroxy- carboxylic acids
None
5.05
36893.0
Lactobacillus paracasei
GenBank Gene Database
M26929
GenBank Protein Database
149538
UniProtKB
P17584
UniProt Accession
DHD2_LACPA
D-HICDH
EC 1.1.1.-
>D-2-hydroxyisocaproate dehydrogenase
MKIIAYGARVDEIQYFKQWAKDTGNTLEYHTEFLDENTVEWAKGFDGINSLQTTPYAAGV
FEKMHAYGIKFLTIRNVGTDNIDMTAMKQYGIRLSNVPAYSPAAIAEFALTDTLYLLRNM
GKVQAQLQAGDYEKAGTFIGKELGQQTVGVMGTGHIGQVAIKLFKGFGAKVIAYDPYPMK
GDHPDFDYVSLEDLFKQSDVIDLHVPGIEQNTHIINEAAFNLMKPGAIVINTARPNLIDT
QAMLSNLKSGKLAGVGIDTYEYETEDLLNLAKHGSFKDPLWDELLGMPNVVLSPHIAYYT
ETAVHNMVYFSLQHLVDFLTKGETSTEVTGPAK
>1008 bp
ATGAAGATTATTGCTTACGGTGCTCGCGTTGACGAGATTCAATATTTCAAGCAATGGGCC
AAGGATACAGGCAACACACTTGAATACCATACAGAATTTCTCGATGAAAACACCGTTGAA
TGGGCTAAAGGGTTTGATGGCATCAATTCATTGCAGACAACGCCATATGCAGCCGGCGTT
TTTGAAAAAATGCACGCGTATGGTATCAAGTTCTTGACGATTCGGAATGTGGGTACGGAT
AACATTGATATGACTGCCATGAAGCAATACGGCATTCGTTTGAGCAATGTACCGGCTTAT
TCGCCAGCAGCGATTGCTGAATTTGCTTTGACCGATACTTTGTACTTGCTACGTAATATG
GGTAAAGTACAGGCGCAACTACAGGCGGGCGATTATGAAAAAGCGGGCACCTTCATCGGT
AAGGAACTCGGTCAGCAAACCGTTGGCGTGATGGGCACCGGTCATATTGGACAGGTTGCT
ATCAAACTGTTCAAAGGCTTTGGCGCCAAAGTGATTGCTTACGATCCTTATCCAATGAAG
GGCGATCACCCAGATTTTGACTATGTCAGCCTTGAAGACCTCTTTAAGCAAAGTGATGTC
ATTGATCTTCATGTTCCTGGGATTGAACAAAATACCCACATTATCAATGAAGCGGCATTT
AATTTGATGAAACCGGGTGCGATTGTGATCAACACGGCTCGGCCAAATCTGATTGACACG
CAAGCCATGCTCAGCAATCTTAAGTCTGGCAAGTTGGCCGGTGTCGGGATTGACACCTAT
GAATACGAAACCGAGGACTTGTTGAATCTCGCCAAGCACGGCAGCTTCAAGGATCCGTTG
TGGGACGAGCTGTTGGGGATGCCAAATGTTGTCCTCAGCCCGCACATTGCCTACTACACC
GAGACGGCTGTGCATAATATGGTTTACTTCTCACTACAACATCTCGTTGATTTCTTGACC
AAATTCAAACCAGCACGGAAGTTACTGGTCCAGCAAGTAGTCAACTGA
PF00389
2-Hacid_dh
PF02826
2-Hacid_dh_C
function
catalytic activity
function
NAD binding
function
oxidoreductase activity
function
cofactor binding
function
coenzyme binding
function
binding
function
oxidoreductase activity, acting on CH-OH group of donors
function
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
process
metabolism
process
L-serine metabolism
process
cellular metabolism
process
L-serine biosynthesis
process
amino acid metabolism
process
amino acid and derivative metabolism
process
serine family amino acid metabolism
process
physiological process
"
|
owl:sameAs |
All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines/drugbank_small.nt
The resource appears as object in 8 triples